JPH0510069B2 - - Google Patents
Info
- Publication number
- JPH0510069B2 JPH0510069B2 JP59243837A JP24383784A JPH0510069B2 JP H0510069 B2 JPH0510069 B2 JP H0510069B2 JP 59243837 A JP59243837 A JP 59243837A JP 24383784 A JP24383784 A JP 24383784A JP H0510069 B2 JPH0510069 B2 JP H0510069B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- glucopyranoside
- sugar
- aminoacylated
- aminobutyryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 aminobutyryl group Chemical group 0.000 claims description 21
- 235000000346 sugar Nutrition 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000002072 seryl group Chemical group 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 229930006000 Sucrose Natural products 0.000 description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 12
- 239000005720 sucrose Substances 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 8
- 235000003599 food sweetener Nutrition 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 239000003765 sweetening agent Substances 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 150000008163 sugars Chemical class 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108010011485 Aspartame Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
- 239000000605 aspartame Substances 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 229960003438 aspartame Drugs 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- VVSWDMJYIDBTMV-UQPQVDFHSA-N (2r,4ar,6s,7r,8r,8as)-6-methoxy-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol Chemical compound C1([C@@H]2OC[C@H]3O[C@@H]([C@@H]([C@@H](O)[C@@H]3O2)O)OC)=CC=CC=C1 VVSWDMJYIDBTMV-UQPQVDFHSA-N 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- USQBHFQIHSGCMU-UHFFFAOYSA-N 2-n,2-n'-dimethyl-1h-pyridine-2,2-diamine Chemical compound CNC1(NC)NC=CC=C1 USQBHFQIHSGCMU-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 150000008501 α-D-glucopyranosides Chemical class 0.000 description 2
- DMBKPDOAQVGTST-LBPRGKRZSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxypropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)COCC1=CC=CC=C1 DMBKPDOAQVGTST-LBPRGKRZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 150000008539 L-glutamic acids Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- ZCHPKWUIAASXPV-UHFFFAOYSA-N acetic acid;methanol Chemical compound OC.CC(O)=O ZCHPKWUIAASXPV-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- QQWYQAQQADNEIC-RVDMUPIBSA-N tert-butyl [(z)-[cyano(phenyl)methylidene]amino] carbonate Chemical compound CC(C)(C)OC(=O)O\N=C(/C#N)C1=CC=CC=C1 QQWYQAQQADNEIC-RVDMUPIBSA-N 0.000 description 1
- FXMNVYBROILAKU-UHFFFAOYSA-N tert-butyl n-[cyano(phenyl)methylidene]carbamate Chemical compound CC(C)(C)OC(=O)N=C(C#N)C1=CC=CC=C1 FXMNVYBROILAKU-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Landscapes
- Seasonings (AREA)
- Saccharide Compounds (AREA)
Description
本発明はアミノアシル化糖又はその塩を甘味付
与材として添加する甘味付与方法に関する。
甘味を呈する物質として代表的なものは蔗糖で
あるが、蔗糖の摂取ないしは過剰摂取が医療上の
理由で制限される場合が多い。特に、糖尿病など
においては、糖の摂取を積極的に制限するため
に、甘味付与に用いる糖の量を減少したり、全く
排除する場合がある。治療を目的としない場合で
も、上記の如き成人病等の予防、むし歯の予防乃
至は肥満の防止のために、近年、蔗糖の摂取量を
減らそうとする傾向が高い。蔗糖の接種の減少又
は排除に伴う甘味の不足を補う目的で使用され
る、いわゆる代用甘味料乃至はダイエツト甘味料
としては、ソルビトール、マルチトール等の糖ア
ルコール、アスパルテームに代表されるジペプチ
ド甘味料、ステビオサイド、グリチルリチン、ア
セサルフアム、サツカリン等があるが、糖アルコ
ール、アスパルテーム等を除くと、甘味質におい
て必ずしも満足はできない。従つて、良質な甘味
質を有し、蔗糖に代替し得る甘味料に対する要望
は依然存在する。
本発明者らは、ペプチドの合成並びに有用性に
関する研究を行う一方、生体内に広く存在するア
ミノ酸と糖がエステル結合したアミノアシル化糖
の合成並びにその有用性に関する研究を行う中
で、特定のアミノアシル化糖が甘味を有し、更に
は、良質で強い甘味を有するアミノアシル化糖の
存在を発見し、本発明を完成した。
アミノ酸、ペプチドの呈味については、従来、
疎水性アミノ酸、アルギニン、プロリンを含む多
くの苦みを呈するアミノ酸、ペプチドに関する報
告があり、グリシン、アラニン等の甘味を呈する
アミノ酸、アスパルテームに代表される甘味ペプ
チドも知られている。
一方、アミノアシル化糖の甘味に関する報告は
グリシン、アラニン、バリン、イソロイシン、プ
ロリン等のアミノアシル化糖及びその塩の呈味機
能に関するもの(特願昭59−46093)を除き全く
知られていない。本発明のアミノアシル化糖は、
化学的合成或いは微生物醗酵による方法等、いか
なる方法で得られるものでもよく、その製法に特
別の限定はない。具体的には、例えば4,6位が
ベンジリデンでブロツクされたエチル−4,6−
O−ベンジリデン−α−D−グルコピラノシドの
2,3位にBoc−アミノ酸をDMAP(ジメチルア
ミノピリジン)存在下、DCC法により導入し、
しかる後にHC/ジオキサン処理によつてBoc
(t−ブトキシカルボニル)及びベンジリデンを
除去する等により目的物のアミノアシル化糖が得
られる。上記アミノアシル化糖を甘味付与剤とし
て添加する場合、それ自体でも又は塩酸塩等の塩
の形でもその甘味発現機能に変りはなく、何れの
形態でも使用可能であり、例えば、化学的合成法
により得られた最終目的物(アミノアシル化糖)
の物性が不安定であつたり、取扱いが困難な場合
には、塩酸塩、硫酸塩、クエン酸塩、酒石酸塩、
マレイン酸塩、フマル酸塩等の形での使用が望ま
しく、特に塩酸塩での使用が甘味付与上好まし
い。
本発明のアミノアシル化糖の例としては、下記
式中、R1がアミノブチリール基又はセリル基で
あり、R2が炭素数1〜6のアルキル基であり、
具体的には、メチル−2,3−ジ−O−(L−α
−アミノブチリール)−α−D−グリコピラノシ
ド、メチル−2,3−ジ−O−(L−セリル)−α
−D−グルコピラノシド、エチル−2,3−ジ−
O−(L−α−アミノブチリール)−α−D−グラ
コピラノシド、エチル2,3−ジ−O−(L−セ
リル)−α−D−グラコピラノシド及びこれらの
塩酸塩等が挙げられる。
式
上記アミノアシル化糖は、L体、D体、DL体
の何れでもよい。また、アミノアシル化糖又はそ
の塩を、各単独で使用しても、或いは2種以上を
併用してもよい。
呈味に関する実験
倍数希釈による官能検査法によりメチル−2,
3−ジ−O−(L−α−アミノブチリール)−α−
D−グルコピラノシド及びメチル−2,3−ジ−
O−(L−セリル)−α−D−グラコピラノシドに
ついて、呈味を評価した。結果は、メチル−2,
3−ジ−O−(L−α−アミノブチリール)−α−
D−グルコピラノシドがシヨ糖の53倍の強い甘味
を有し、メチル−2,3−ジ−O−(L−セリル)
−α−D−グラコピラノシドは、シヨ糖の3.4倍
の甘味を有していた。
The present invention relates to a method for imparting sweetness by adding aminoacylated sugar or a salt thereof as a sweetening agent. Sucrose is a typical sweet-tasting substance, but intake or excessive intake of sucrose is often restricted for medical reasons. In particular, in patients with diabetes and the like, in order to actively limit sugar intake, the amount of sugar used for sweetening may be reduced or eliminated altogether. In recent years, there has been a strong tendency to reduce the intake of sucrose, even if it is not intended for treatment, in order to prevent adult diseases such as those mentioned above, to prevent dental caries, and to prevent obesity. So-called substitute sweeteners or dietary sweeteners used to compensate for the lack of sweetness due to reduction or elimination of sucrose inoculation include sugar alcohols such as sorbitol and maltitol, dipeptide sweeteners typified by aspartame, There are stevioside, glycyrrhizin, acesulfam, saccharin, etc., but unless sugar alcohols, aspartame, etc. are excluded, the quality of sweetness is not necessarily satisfactory. Therefore, there is still a need for a sweetener that has good sweetness and can replace sucrose. The present inventors conducted research on the synthesis and usefulness of peptides, and while conducting research on the synthesis and usefulness of aminoacylated sugars in which amino acids and sugars, which are widely present in living organisms, are ester-bonded, The present invention was completed by discovering that high-fructose sugar has a sweet taste, and furthermore, the existence of aminoacylated sugar that is of good quality and has a strong sweet taste. Regarding the taste of amino acids and peptides,
There have been reports on many amino acids and peptides that exhibit a bitter taste, including hydrophobic amino acids, arginine, and proline, and amino acids that exhibit a sweet taste, such as glycine and alanine, and sweet peptides, such as aspartame, are also known. On the other hand, there are no reports regarding the sweetness of aminoacylated sugars, except for those regarding the taste functions of aminoacylated sugars such as glycine, alanine, valine, isoleucine, and proline, and their salts (Japanese Patent Application No. 46093/1982). The aminoacylated sugar of the present invention is
It may be obtained by any method such as chemical synthesis or microbial fermentation, and there are no particular limitations on the manufacturing method. Specifically, for example, ethyl-4,6-blocked with benzylidene at the 4 and 6 positions.
Boc-amino acids were introduced into the 2nd and 3rd positions of O-benzylidene-α-D-glucopyranoside by the DCC method in the presence of DMAP (dimethylaminopyridine),
After that, Boc was treated with HC/dioxane.
(t-butoxycarbonyl) and benzylidene are removed to obtain the desired aminoacylated sugar. When the above-mentioned aminoacylated sugar is added as a sweetening agent, there is no change in its sweetness-producing function whether it is added by itself or in the form of a salt such as hydrochloride, and it can be used in any form.For example, it can be added by chemical synthesis method. Obtained final target product (aminoacylated sugar)
If the physical properties of
It is preferable to use it in the form of a maleate salt, a fumarate salt, etc., and the use of a hydrochloride salt is particularly preferable in terms of imparting sweetness. Examples of the aminoacylated sugar of the present invention include, in the following formula, R 1 is an aminobutyryl group or a seryl group, R 2 is an alkyl group having 1 to 6 carbon atoms,
Specifically, methyl-2,3-di-O-(L-α
-aminobutyryl)-α-D-glycopyranoside, methyl-2,3-di-O-(L-seryl)-α
-D-glucopyranoside, ethyl-2,3-di-
Examples include O-(L-α-aminobutyryl)-α-D-gracopyranoside, ethyl 2,3-di-O-(L-seryl)-α-D-gracopyranoside, and hydrochlorides thereof. formula The above aminoacylated sugar may be any of L-form, D-form, and DL-form. Moreover, each aminoacylated sugar or its salt may be used alone, or two or more types may be used in combination. Experiments on taste: Methyl-2,
3-di-O-(L-α-aminobutyryl)-α-
D-glucopyranoside and methyl-2,3-di-
O-(L-seryl)-α-D-gracopyranoside was evaluated for taste. The result is methyl-2,
3-di-O-(L-α-aminobutyryl)-α-
D-glucopyranoside is 53 times sweeter than sucrose, and methyl-2,3-di-O-(L-seryl)
-α-D-gracopyranoside was 3.4 times sweeter than sucrose.
【表】
ル
セリル 甘味 1.46 3.4
本発明の甘味付与方法は、アミノアシル化糖又
はその塩の中から選ばれた1種又は2種以上の成
分のみを添加するか、或いは他の成分と併用して
食用材料に添加する。併用される他の成分として
は、シヨ糖、ブドウ糖、乳糖、ソルビトール、マ
ルチトール、アスパルテーム、ステビオサイド、
グリチルリチンその他の甘味付与成分、塩化ナト
リウム、塩化カリウムその他の塩味付与成分、ア
ミノ酸、その塩類、L−グルタミン酸、L−グル
タミン酸塩類、5′−イノシン酸及び5′−グアニル
酸塩等の5′ヌクレオチドの塩類、コハク酸塩、動
物蛋白加水分解物、植物蛋白加水分解物、酵母エ
キス等のエキス類その他の旨味付与成分、グルタ
ミン酸、フマル酸、クエン酸、リンゴ酸、酒石
酸、アスコルビン酸等の酸味付与成分その他のい
ずれの成分を組合せることも可能である。
食品(又は医薬)に好ましい甘味を付与するに
は、例えばメチル−2,3−ジ−O−(L−α−
アミノブチリール)−α−D−グルコピラノシド
(塩酸塩)の単独添加の場合、1/50〜1/55のモル
濃度比で蔗糖に相当する甘味が得られるが、共存
する他の呈味成分、食用材料、目的とする甘味の
強さ等に応じて、好ましい添加量は変化する。
本発明の甘味付与方法は、各種の食品、飲料、
医薬等、甘味付与を必要とするあらゆる種類の食
用材料に対しても適用可能であり、アミノ酸及び
糖から構成される甘味付与剤による甘味付与方法
としてその有用性が明らかである。
尚、本発明の対象となる食用材料としては、ジ
ユース、コーラ等の飲料、果物製品、アイスクリ
ーム、シヤーベツト等の冷菓、ゼリー、プデイン
グ、ヨーグルト、チヨコレート、チユーインガ
ム、キヤンデイ、ケーキ、和菓子類等の食品、飲
料、甘味剤(粉末、顆粒、キユーブ、シロツプ
等)、歯みがき、その他の口腔剤、糖衣錠、粉末
製剤、顆粒製剤、シロツプ製剤等の医薬等、いず
れの食用材料であつてもよい。
次に製造例、実施例により本発明を更に説明す
る。なお、製造例における略号は以下の通りであ
る。
Boc− t−ブトキシカルボニル基
Boc−ON 2−t−ブトキシカルボニルイミノ
−2−フエニルアセトニトリル
DCC ジシクロヘキシルカルボジイミド
DCUrea N,N′−ジシクロヘキシルウレア
TEA トリエチルアミン
THF テトラヒドロフラン
DMAP 4−ジメチルアミノピリジン
GM クロロホルム−メタノール(5:1)
製造例
1 糖原料・メチル−4,6−O−ベンジリデン
−α−D−グルコピラノシドの合成
(1) 無水グルコース200gを塩酸を25%含有す
るメタノール500mlと除湿して油浴上18時間
煮沸還流した。反応後氷室中に放置して母核
を加えると結晶が析出した。その結晶をろ過
し、メタノールで洗い、母液を再び濃縮する
とさらに結晶が析出した。得られた結晶を合
わせメタノールから再結晶し、メチル−α−
D−グルコピラノシドの結晶を得た。
収量 97g(45%)
m.p. 166℃
〔α〕25 D +159°(c1.0,H2O)
Rf 0.02(展開溶媒 CM)
C7H14O6としての
計算値 C,43.29%,H,7.27%,O,49.44
%
実測値 C,43.11%,H,7.41%,O,49.48
%
(2) メチル−α−D−グルコピラノシド28gを
ベンズアルデヒド70mlに懸濁し、塩化亜鉛21
gを加え室温で攪拌した。3時間後反応液を
酢酸エチルに溶解し、水で洗浄した。有機層
を無水硫酸ナトリウムで乾燥後、濃縮しエー
テルで結晶化した。
収量 30g(74%)
m.p. 161−167℃
〔α〕25 D (c1.0,CHC3)
Rf 0.58(CM)
C14H18O6としての
計算値 C,59.56%,H,6.43%,O,34.01
%
実測値 C,59.48%,H,6.39%,O,34.13
%
2 メチル−2,3−ジ−O−(L−α−アミノ
ブチリール)−α−D−グルコピラノシドの合
成
(1) メチル=4,6−O−ベンジリデン−2,
3−ジ−O−〔N−(t−ブトキシカルボニ
ル)−L−α−アミノブチリール〕−α−D−
グルコピラノシドの合成
N−(T−t−ブトキシカルボニル)−L−α−
アミノ酪酸ジシクロヘキシルアンモニウム塩
(2.54g、6mmol)を酢酸エチルに懸濁し、2N−
H2SO4と激しく攪拌した。有機層を無水Na2SO4
で乾燥後濃縮し、油状物を得た。この油状物を
THF5mlに溶解し、氷浴で冷却しながらジシクロ
ヘキシルカルボジイミド(DCC)(1.24g、
6mmol)を加え、0℃で20min攪拌した。そのも
のへ続いてメチル=4,6−O−ベンジリデン−
α−D−グルコピラノシド(0.57g、2mmol)と
2,2−ジメチルアミノピリジン(65mg)を
THF5mlに溶解したものを加えた。一夜攪拌後、
N,N′−ジシクロヘキシルウレアを去し、
液を濃縮して酢酸エチルに溶解した。有機層を
水、4%クエン酸、水、4%炭酸水素ナトリウ
ム、水の順で洗い、無水Na2SO4で乾燥させた。
減圧、濃縮の後、残渣をシリカゲルカラムクロマ
トクラフイー(溶媒:ヘキサン−酢酸エチル=
4:1)で精製し、固形物0.56g(1.28mmol、
64%)を得た。
m.p. 135−136℃
〔α〕25 D +37°(c1,CHC3)
Rf 0.42(ヘキサン/酢酸エチル=2/1)
C32H48O12N2としての
計算値 C,58.88%,H,7.39%,O,4.28%
実測値 C,59.01%,H,7.35%,O,4.30%
(2) メチル=2,3−ジ−O−(L−α−アミ
ノブチリール)−α−D−グルコピラノシド
の合成。
メチル=4,6−O−ベンジリデン−2,3−
ジ−O−〔N−(t−ブトキシカルボニル)−L−
α−アミノブチリール〕−α−D−グルコピラノ
シド(391mg、0.6mmol)に4.3N HCをジオキ
サンに溶解したもの(10ml)を加えた。反応終了
後、濃縮しエーテルを加えて固化させた。収率96
%
m.p. 110℃
〔α〕25 D +88°(c1,MeOH)
Rf 0.41(1−BuOH/AcOH/Py/H2O=
4/1/1/2)
C14H30O8N2C2としての
計算値 C,39.44%,H,7.09%,N,6.57%
実測値 C,39.38%,H,7.15%,N,6.51%
3 メチル=2,3−ジ−O−(L−α−セリル)
−α−D−グルコピラノシドの合成。
(1) メチル=4,6−O−ベンジリデン−2,
3−ジ−O−〔N−(t−ブトキシカルボニ
ル)−O−ベンジルセリル〕−α−D−グルコ
ピラノシドの合成
N−(t−ブトキシカルボニル)−O−ベンジル
−L−セリン(1.78g、6mmol)、DCC(1.24g、
6mmol)、メチル4,6−O−ベンジリデン−α
−D−グルコピラノシド(0.57g、2mmol)、2,
2−ジメチルアミノピリジン(65mg)をメチル=
4,6−O−ベンジリデン−2,3−ジ−O−
〔N−(t−ブトキシカルボニル)−L−α−アミ
ノブチリール〕−α−D−グルコピラノシドの合
成と同様に行ない、吸湿性の結晶を得た。収率63
%
m.p. (hygroscopic)
〔α〕25 D +8°(c1,CHC3)
C44H56O14N2としての
計算値 C,63.14%,H,6.74%,N,3.34%
実測値 C,63.09%,H,6.71%,N,3.37%
(2) メチル=2,3−ジ−O−(L−セリル)−
α−D−グルコピラノシドの合成。
メチル=4,6−O−ベンジリデン−2,3−
ジ−O−〔N−(t−ブトキシカルボニル)−O−
α−ベンジル−L−セリル〕−α−D−グルコピ
ラノシド(502mg、0.6mmol)を4.3N HC/ジ
オキサンに(10ml)でBoc基とベンジリデン基と
を除去した。減圧濃縮後、AcOH−MeOH(1:
1)(10ml)に溶解しパラジウム黒を用いて接触
還元を行ない、ベンジル基を除去した。パラジウ
ム黒を去後濃縮し、得られた残渣にアセトンを
加え、吸湿性の結晶を得た。収率78%
m.p. (hygroscopic)
〔α〕25 D +69°(c1,MeOH)
C13H26N2O10C2としての
計算値 C,35.38%,H,5.93%,N,6.35%
実測値 C,35.29%,H,5.97%,N,6.31%
実施例 1
インスタントコーヒー1人前2gを熱湯1人前
各150mlに溶解し、コーヒー液を調製した。この
コーヒー液に製造例で得たメチル−2,3−ジ−
O−(L−α−アミノブチリール)−α−D−グル
コピラノシド・2塩酸塩(サンプルA)又はメチ
ル−2,3−ジ−O−(L−セリル)−α−D−グ
ルコピラノシド・2塩酸塩(サンプルB)をそれ
ぞれ溶解したもの(試験区)並びに蔗糖を溶解し
たもの(対照区)をそれぞれ調製し、よく訓練さ
れた味覚パネル20名を用いて、2点比較法によ
り、官能評価を実施した。結果を第2表に示す。
(サンプルA〜B及び蔗糖の添加濃度)
サンプルA 0.15g/dl
B 1.4 ″
蔗糖 6 ″[Table] Luceril Sweetness 1.46 3.4
In the sweetening method of the present invention, one or more components selected from aminoacylated sugars or salts thereof are added alone or in combination with other components to an edible material. Other ingredients used in combination include sucrose, glucose, lactose, sorbitol, maltitol, aspartame, stevioside,
Glycyrrhizin and other sweetening ingredients, sodium chloride, potassium chloride and other salty flavoring ingredients, amino acids, their salts, 5' nucleotides such as L-glutamic acid, L-glutamic acid salts, 5'-inosinic acid and 5'-guanylate Salts, succinates, animal protein hydrolysates, plant protein hydrolysates, extracts such as yeast extract, and other flavor-imparting ingredients, acidity-imparting ingredients such as glutamic acid, fumaric acid, citric acid, malic acid, tartaric acid, ascorbic acid, etc. Combinations of any other ingredients are also possible. For example, methyl-2,3-di-O-(L-α-
When adding aminobutyryl)-α-D-glucopyranoside (hydrochloride) alone, a sweetness equivalent to that of sucrose can be obtained at a molar concentration ratio of 1/50 to 1/55, but other taste components that coexist, The preferred amount to be added varies depending on the edible material, the desired intensity of sweetness, etc. The sweetening method of the present invention can be applied to various foods, beverages,
It can be applied to all kinds of edible materials that require sweetening, such as pharmaceuticals, and its usefulness as a method for imparting sweetness using a sweetener composed of amino acids and sugars is clear. The edible materials covered by the present invention include beverages such as juice and cola, fruit products, frozen desserts such as ice cream and sherbett, foods such as jelly, pudding, yogurt, chocolate, chewing gum, yellowtail, cakes, and Japanese sweets. It may be any edible material, such as beverages, sweeteners (powders, granules, cubes, syrups, etc.), toothpastes, other oral preparations, sugar-coated tablets, powder preparations, granule preparations, syrup preparations, and other pharmaceuticals. Next, the present invention will be further explained with reference to production examples and examples. In addition, the abbreviations in the manufacturing examples are as follows. Boc- t-butoxycarbonyl group Boc-ON 2-t-butoxycarbonylimino-2-phenylacetonitrile DCC dicyclohexylcarbodiimide DCU rea N,N'-dicyclohexylurea TEA triethylamine THF tetrahydrofuran DMAP 4-dimethylaminopyridine GM chloroform-methanol ( 5:1) Production Example 1 Synthesis of sugar raw material - methyl-4,6-O-benzylidene-α-D-glucopyranoside (1) 200 g of anhydrous glucose was dehumidified with 500 ml of methanol containing 25% hydrochloric acid and heated on an oil bath for 18 hours. Boil at reflux for an hour. After the reaction, the mixture was left in an ice chamber and a mother nucleus was added to precipitate crystals. The crystals were filtered, washed with methanol, and the mother liquor was concentrated again to precipitate more crystals. The obtained crystals were combined and recrystallized from methanol to give methyl-α-
Crystals of D-glucopyranoside were obtained. Yield 97g (45%) mp 166℃ [α] 25 D +159° (c1.0, H 2 O) R f 0.02 (developing solvent CM) Calculated value as C 7 H 14 O 6 C, 43.29%, H, 7.27%, O, 49.44
% Actual value C, 43.11%, H, 7.41%, O, 49.48
% (2) Suspend 28 g of methyl-α-D-glucopyranoside in 70 ml of benzaldehyde and add 21 g of zinc chloride.
g and stirred at room temperature. After 3 hours, the reaction solution was dissolved in ethyl acetate and washed with water. The organic layer was dried over anhydrous sodium sulfate, concentrated, and crystallized from ether. Yield 30g (74%) mp 161-167℃ [α] 25 D (c1.0, CHC 3 ) R f 0.58 (CM) Calculated value as C 14 H 18 O 6 C, 59.56%, H, 6.43%, O, 34.01
% Actual value C, 59.48%, H, 6.39%, O, 34.13
% 2 Synthesis of methyl-2,3-di-O-(L-α-aminobutyryl)-α-D-glucopyranoside (1) Methyl=4,6-O-benzylidene-2,
3-di-O-[N-(t-butoxycarbonyl)-L-α-aminobutyryl]-α-D-
Synthesis of glucopyranoside N-(T-t-butoxycarbonyl)-L-α-
Aminobutyric acid dicyclohexylammonium salt (2.54 g, 6 mmol) was suspended in ethyl acetate, and 2N-
Stir vigorously with H2SO4 . Dilute the organic layer with anhydrous Na 2 SO 4
After drying and concentrating, an oily substance was obtained. This oily substance
Dicyclohexylcarbodiimide (DCC) (1.24 g,
6 mmol) was added thereto, and the mixture was stirred at 0°C for 20 min. followed by methyl 4,6-O-benzylidene-
α-D-glucopyranoside (0.57g, 2mmol) and 2,2-dimethylaminopyridine (65mg)
A solution dissolved in 5 ml of THF was added. After stirring overnight,
Remove N,N′-dicyclohexylurea,
The liquid was concentrated and dissolved in ethyl acetate. The organic layer was washed sequentially with water, 4% citric acid, water, 4% sodium bicarbonate, and water, and dried over anhydrous Na 2 SO 4 .
After vacuum concentration and concentration, the residue was subjected to silica gel column chromatography (solvent: hexane-ethyl acetate =
4:1) to give 0.56 g (1.28 mmol,
64%). mp 135−136℃ [α] 25 D +37° (c1, CHC 3 ) R f 0.42 (hexane/ethyl acetate = 2/1) Calculated value as C 32 H 48 O 12 N 2 C, 58.88%, H, 7.39%, O, 4.28% Actual value C, 59.01%, H, 7.35%, O, 4.30% (2) Methyl = 2,3-di-O-(L-α-aminobutyryl)-α-D- Synthesis of glucopyranosides. Methyl=4,6-O-benzylidene-2,3-
di-O-[N-(t-butoxycarbonyl)-L-
To α-aminobutyryl]-α-D-glucopyranoside (391 mg, 0.6 mmol) was added a solution of 4.3N HC in dioxane (10 ml). After the reaction was completed, it was concentrated and solidified by adding ether. Yield 96
% mp 110℃ [α] 25 D +88° (c1, MeOH) R f 0.41 (1-BuOH/AcOH/Py/H 2 O=
4/1/1/2) C 14 H 30 O 8 N 2 Calculated value as C 2 C, 39.44%, H, 7.09%, N, 6.57% Actual value C, 39.38%, H, 7.15%, N, 6.51% 3 Methyl = 2,3-di-O-(L-α-seryl)
-Synthesis of α-D-glucopyranoside. (1) Methyl = 4,6-O-benzylidene-2,
Synthesis of 3-di-O-[N-(t-butoxycarbonyl)-O-benzylseryl]-α-D-glucopyranoside N-(t-butoxycarbonyl)-O-benzyl-L-serine (1.78 g, 6 mmol ), DCC (1.24g,
6mmol), methyl 4,6-O-benzylidene-α
-D-glucopyranoside (0.57g, 2mmol), 2,
2-dimethylaminopyridine (65mg) to methyl =
4,6-O-benzylidene-2,3-di-O-
Hygroscopic crystals were obtained in the same manner as the synthesis of [N-(t-butoxycarbonyl)-L-α-aminobutyryl]-α-D-glucopyranoside. Yield 63
% mp (hygroscopic) [α] 25 D +8° (c1, CHC 3 ) Calculated value as C 44 H 56 O 14 N 2 C, 63.14%, H, 6.74%, N, 3.34% Actual value C, 63.09% , H, 6.71%, N, 3.37% (2) Methyl=2,3-di-O-(L-seryl)-
Synthesis of α-D-glucopyranoside. Methyl=4,6-O-benzylidene-2,3-
di-O-[N-(t-butoxycarbonyl)-O-
α-Benzyl-L-seryl]-α-D-glucopyranoside (502 mg, 0.6 mmol) was treated with 4.3 N HC/dioxane (10 ml) to remove the Boc and benzylidene groups. After concentration under reduced pressure, AcOH-MeOH (1:
1) (10 ml) and subjected to catalytic reduction using palladium black to remove the benzyl group. After removing the palladium black, it was concentrated, and acetone was added to the resulting residue to obtain hygroscopic crystals. Yield 78% mp (hygroscopic) [α] 25 D +69° (c1, MeOH) Calculated value as C 13 H 26 N 2 O 10 C 2 C, 35.38%, H, 5.93%, N, 6.35% Actual value C, 35.29%, H, 5.97%, N, 6.31% Example 1 A coffee liquid was prepared by dissolving 2 g of one serving of instant coffee in 150 ml of each serving of hot water. In this coffee liquid, methyl-2,3-di-
O-(L-α-aminobutyryl)-α-D-glucopyranoside dihydrochloride (sample A) or methyl-2,3-di-O-(L-seryl)-α-D-glucopyranoside dihydrochloride A solution of salt (sample B) (test group) and a solution of sucrose (control group) were prepared, and sensory evaluation was conducted using a two-point comparison method using 20 well-trained taste panels. carried out. The results are shown in Table 2.
(Samples A to B and sucrose concentration) Sample A 0.15g/dl B 1.4″ Sucrose 6″
【表】【table】
【表】【table】
【表】
あらかじめスイートチヨコレート(本発明品は
ビターチヨコレート、本発明の化合物、デキスト
リン、カカオバターで、対照品はビターチヨコレ
ート、砂糖、カカオバターで)を調製したのち、
卵、生クリームを使用し、常法によりチヨコレー
トムースを調製した。
得られた2種類のチヨコレートムースを冷蔵庫
で1日間保存冷却し、固めた後、味覚パネル20名
による官能評価を実施した。
結果を第3表に示す。評価結果及びコメントか
ら本発明品は、蔗糖添加品と同様さわやかな甘
味、苦味を呈し、嗜好性も良い評価が得られた。[Table] After preparing sweet chocolate in advance (the product of the present invention contains bitter chocolate, the compound of the present invention, dextrin, and cocoa butter; the control product contains bitter chocolate, sugar, and cocoa butter),
Chiyocolate mousse was prepared by a conventional method using eggs and fresh cream. The two types of thiokolate mousses obtained were stored in a refrigerator for one day to cool and solidify, and then sensory evaluation was performed by 20 taste panels. The results are shown in Table 3. Based on the evaluation results and comments, the product of the present invention exhibited refreshing sweetness and bitterness similar to the sucrose-added product, and was evaluated as having good palatability.
Claims (1)
基であり、R2は低級アルキル基である。)を有す
るアミノアシル化糖又はその塩を食用材料に添加
することを特徴とする甘味付与方法。[Claims] 1 Formula: (In the formula, R 1 is an aminobutyryl group or a seryl group, and R 2 is a lower alkyl group.) A method for imparting sweetness, which comprises adding an aminoacylated sugar or a salt thereof to an edible material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59243837A JPS61124354A (en) | 1984-11-19 | 1984-11-19 | Sweetening method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59243837A JPS61124354A (en) | 1984-11-19 | 1984-11-19 | Sweetening method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61124354A JPS61124354A (en) | 1986-06-12 |
JPH0510069B2 true JPH0510069B2 (en) | 1993-02-08 |
Family
ID=17109678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59243837A Granted JPS61124354A (en) | 1984-11-19 | 1984-11-19 | Sweetening method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61124354A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6071126B2 (en) * | 2013-02-06 | 2017-02-01 | 微小循環研究所 有限会社 | Glycine sweet seasoning with a sweetness level visible |
EP3050893B1 (en) | 2013-09-24 | 2020-02-26 | Ajinomoto Co., Inc. | Glycoamino acid and use thereof |
JP6601220B2 (en) * | 2014-01-21 | 2019-11-06 | 味の素株式会社 | Sugar amino acids and their uses |
-
1984
- 1984-11-19 JP JP59243837A patent/JPS61124354A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61124354A (en) | 1986-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4117173A (en) | Use of glucopyranosido-1,6-mannitol as a sugar substitute | |
KR100254297B1 (en) | Compounds useful as sweetening agents and process for their preparation | |
US20020081360A1 (en) | Salts of L-amino acid having improved taste and their preparation | |
JPH022327A (en) | Sweetener having heterocyclic group | |
US3907766A (en) | L-aspartyl-aminomalonic acid diester | |
US4877895A (en) | Glycine and β alanine derivatives as sweetening agents | |
US3978034A (en) | L-Aspartyl dipeptides as sweetening agents | |
EP0417256B1 (en) | Novel n-(sulfomethyl)-n'-arylureas | |
US3972860A (en) | L-aspartyl-L-phenylglycine esters of lower alkanols | |
Khan et al. | Low calorie high-intensity sweeteners | |
JPH0510069B2 (en) | ||
US3959245A (en) | L-Aspartyl-aminomalonic acid methyl 2-methylcyclohexyl diester | |
US4692513A (en) | Alpha-L-aspartyl-D-heteroaromatic-substituted glycine esters and amides useful as high intensity sweeteners | |
US4692512A (en) | Alpha-L-aspartyl-D-phenylglycine esters and amides useful as high intensity sweeteners | |
JPH0569496B2 (en) | ||
RU2138511C1 (en) | N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-HEXAHYDROPHENYLALANINE METHYL ESTER AS SWEETENER AND METHOD OF PREPARATION THEREOF | |
US6649784B2 (en) | Aspartyl dipeptide ester derivatives and sweeteners | |
RU2238945C2 (en) | Compositions of high-intensive sweetening agents with improved sweetness, taste modifying agent and their application | |
EP0310341B1 (en) | N-(l-aspartyl)amino alcohol derivatives and sweetener containing the same | |
JPS60188037A (en) | Method of enhancing tastiness | |
JPS61291596A (en) | L-aspartyl-d-alanine-(+), beta-fenchyl ester | |
JPS61200999A (en) | Aspartylalanine 2-pinanyl or fenchyl ester | |
JPS61177963A (en) | Sweetness imparter | |
RU2174983C2 (en) | N-(s)-1-phenyl-1-alkaneamide as sweetening agent | |
JP3060385B2 (en) | Novel lactitol anhydride crystals, honey-containing crystals containing the same and methods for producing them |